Completed PHASE4 INTERVENTIONAL 3-arm NCT01496846

Efficacy Study of Articaine Versus Lidocaine as Supplemental Infiltration in Inflamed Molars (ARTIC)

Articaine Versus Lidocaine Supplemental Infiltration Efficacy in Irreversible Pulpitis Mandibular Molars After Failed Inferior Alveolar Nerve Block

Sponsor: Dentsply International

Conditions Irreversible Pulpitis

Interventions IANB Articaine SUP Articaine SUP Lidocaine

Updated 8 times since 2017 Last updated: Sep 27, 2017 Started: Sep 30, 2011 Primary completion: Feb 29, 2016 Completion: Feb 29, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01496846, this PHASE4 trial focuses on Irreversible Pulpitis and remains completed. Sponsored by Dentsply International, it has been updated 8 times since 2011, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Nov 2017 — Jun 2018 [monthly]

Completed PHASE4

▶ Show 3 earlier versions

Oct 2017 — Nov 2017 [monthly]

Completed PHASE4
Feb 2017 — Oct 2017 [monthly]

Completed PHASE4
Jan 2017 — Feb 2017 [monthly]

Completed PHASE4

First recorded

Sep 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Dentsply International
University of Michigan

Data source: University of Michigan

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Ann Arbor, United States